PHIO Phio Pharmaceuticals Corp. Sotuvning sof marjinal rentabelligi

Ommaviy kompaniya Phio Pharmaceuticals Corp. (PHIO) logotipi

GURU.Markets platformasi tomonidan taqdim etilgan Phio Pharmaceuticals kompaniyasining sof marja samaradorligi 0.00 ko'rsatkichning joriy qiymati bo'lgan modelning barqarorligini namoyish etadi. Phio Pharmaceuticals INTASYL platformasi orqali RNK interferentsiyasini ishlab chiqmoqda va eksklyuziv davolash protokollarini yaratmoqda. Jamoa akademik erkinlikka ega bo'lgan yetakchi saraton genetiklarini birlashtiradi. Texnologik stek robotlashtirilgan molekulalarni skrining qilish va bashorat qiluvchi dasturiy ta'minot bilan to'ldirilgan.

PHIO: Phio Pharmaceuticals Corp Sotuvning sof marjinal rentabelligi 04.07.2022 - 19.11.2026

phiopharma.com (PHIO) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning asosiy tahlili:RXi Pharmaceuticals - PHIO
Phio Pharmaceuticals yetakchi tovari

Sof foyda marjasi sof foydaning umumiy daromadga nisbati sifatida hisoblanadi. Ushbu koeffitsient xarajatlarni boshqarish samaradorligini va sotuvlarning har bir birligining fundamental daromadliligini o'lchaydi. Phio Pharmaceuticals (PHIO) uchun ushbu ko'rsatkich immuno-onkologiya kontekstida INTASYL RNA interferensiya platformasining ishlab chiqish xarajatlarini aks ettiradi. Yillik sof foyda marjasidagi tendentsiya investorlarga operatsion samaradorlikning haqiqiy o'sishini spekulyativ vasvasadan ajratish imkonini beradi. Yillik sof foyda marjasining trayektoriyasi potentsial daromadlar va haddan tashqari to'lov qilish xavfi o'rtasidagi muvozanatni belgilaydi.

Raqobatchilar tahlili

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|QURE: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MeiraGTx PLC|RGNX (REGENXBIO Inc) - Sotuvning sof marjinal rentabelligi|solidbio.com (SLDB) - Kompaniya sotuv marjasi|Sof marja Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning sof rentabelligi|Benitec Biopharma - Sof foyda bo'yicha sotuv rentabelligi|DSGN: Sotuvning sof rentabelligi|RCKT: Sof foyda bo'yicha sotuv rentabelligi|FDMT - Sotuvning sof marjinal rentabelligi|LXEO: Sotuvning sof marjinal rentabelligi|Korro Bio Inc. - Sof foyda normasi|EDIT (editasmedicine.com) - Sotuvning sof marjinal rentabelligi|Sof marja SLN|Sof marja ProQR Therapeutics NV (PRQR)|Codexis - Sotuvning sof rentabelligi|Sof marja Sangamo SGMO|NAUT: Sotuvning sof rentabelligi|MGX: Sof foyda bo'yicha sotuv rentabelligi|Sof marja Precision BioSciences|GBIO (generationbio.com) - Sof foyda bo'yicha sotuv rentabelligi|Sof marja boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi IMNN (Imunon, Inc.)|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX